- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05301959
Efficacy of Percutaneous Electrolysis in the Treatment of Achilles Tendinopathy
Evaluation of the Efficacy of Adding Low-intensity Percutaneous Musculoskeletal Electrolysis to the Conservative Treatment of Noninsertional Achilles Tendinopathy: a Randomized Controlled Clinical Trial
Achilles tendinopathy (AT) is one of the most reported myotendinous pathologies due to overuse in the literature. In the general adult population, its incidence is 2.35 cases per 1,000 patients, with no difference between men and women. The international literature reports that up to 29% of patients fail with conservative treatment.
Within physiotherapy, new alternatives for the treatment of tendinopathies arise, applying electric currents percutaneously, which from a mechanical effect associated to the use of a needle and an electric effect by the use of galvanic currents, generate a local inflammatory response; activation of the central nervous system and analgesia.
The aim of the research is to evaluate the efficacy of adding low intensity percutaneous electrolysis to the treatment with a high load eccentric exercise program based on the protocol of Silbernagel et al. in adults with Achilles tendinopathy to improve its functionality.
A randomized, double-blind, blinded, evaluator-blinded, controlled clinical trial will be conducted in parallel groups (experimental treatment vs. sham treatment), with a follow-up at 26 and 52 weeks after the first intervention. Non-probability and intentional sampling will be performed.
Study Overview
Status
Conditions
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Santiago M d'Almeida, PT SCS
- Phone Number: 01140573099
- Email: dalmeida.santiago@maimonides.edu
Study Locations
-
-
Caba
-
Ciudad Autonoma de Buenos Aires, Caba, Argentina, 1405
- Recruiting
- Maimonides University
-
Contact:
- Oscar Ronzio, DHSc
- Phone Number: +541149051140
- Email: ronzio.oscar@maimonides.edu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Presence of symptoms in one or both Achilles tendons with a minimum duration of two months. In case the symptoms are bilateral, the intervention or placebo will only be administered and its results evaluated- in the limb with greater symptomatology. If it is not possible to differentiate which one presents greater pain, the right Achilles tendon will be chosen.
- Spontaneous pain of at least three points measured by a visual analog scale (VAS), reproducible by palpation between 2 and 6 cm above the insertion of the Achilles tendon in the calcaneal bone.
- Evidence of tendinopathy by MRI.
- Presence of post-static dyskinesia.
- Willingness to not perform additional treatments (such as footwear modifications, physical therapy, orthotics, injections, or surgery) for Achilles tendon pain during the conduct of the trial.
- Willingness to attempt to discontinue self-administration of medications (NSAIDs) for pain relief Achilles tendon(s) pain for at least 14 days prior to baseline assessment and during the course of the trial.
Exclusion Criteria:
- Presence or suspicion of pregnancy.
- Previous surgical intervention on the AT in the symptomatic leg(s)
- Total or partial rupture in the symptomatic AT
- Chronic ankle instability, in the foot with symptomatic tendon(s).
- Pathologies that can derive in pain in the region of the AT without being proper of the picture. (e.g.: osteoarthritis, impingement syndromes).
- Presence of arthritis or any metabolic or endocrine disorder (type 1 or 2 diabetes).
- Psychological disorders.
- Oncologic history.
- Treatment with quinolones or fluoroquinolones during the last two years.
- Treatment with statins for the control of hypercholesterolemia for more than two months
- Treatments within or at the periphery of the Achilles tendon, with anesthetics, corticosteroids or any other pharmacological agent during the last three months.
- Needle phobia
- Allergy to metal
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Experimental group
A single weekly intervention of low intensity galvanic currents will be applied in an ultrasound-guided manner.
|
An acupuncture needle (0.30mm X 25mm) will be introduced into the device's strut.
With the equipment on and with a base intensity of 120µA, the acupuncture needle is introduced in a proximal-distal and postero-anterior direction, in the area of the Achilles tendon body.
The position of the needle will be checked with ultrasound and once the point to be treated is reached, the working intensity will be increased up to 600 µA.
The emission will be maintained until the participant reports a pain of 60/100 in VAS.
At that moment, the emission will be paused completely until the participant reports a sensation of at least 20/100 in VAS.
After this period the emission will be continued at 600 µA.
This cycle will continue until the emission lasts for more than 120 sec, continuously.
At this point, the needle will be repositioned to repeat the emission protocol a maximum of 3 times in total.
Other Names:
The Silbernagel et al. protocol comprises several heel raising exercises with concentric and eccentric movements, performed on two legs and one leg.
It is composed of 3 sets of 15 repetitions and that during the exercises allows pain to be present, but not being disabling.
The exercises will be performed only once a day.
The progression will be made by changing from standing exercises to monopodal support, moving from concentric-eccentric to purely eccentric loading, adding weight in a backpack (in steps of 5 kg when pain does not exceed 5 in the pain monitoring model) and finally using fast rebound exercises and plyometric exercises.
Other Names:
|
Sham Comparator: Simulated group.
The application of a single weekly intervention of low intensity galvanic currents will be simulated in an echogenic way, with the equipment turned off.
|
The Silbernagel et al. protocol comprises several heel raising exercises with concentric and eccentric movements, performed on two legs and one leg.
It is composed of 3 sets of 15 repetitions and that during the exercises allows pain to be present, but not being disabling.
The exercises will be performed only once a day.
The progression will be made by changing from standing exercises to monopodal support, moving from concentric-eccentric to purely eccentric loading, adding weight in a backpack (in steps of 5 kg when pain does not exceed 5 in the pain monitoring model) and finally using fast rebound exercises and plyometric exercises.
Other Names:
A modification will be made in a second equipment, closing the circuit with a 10kΩ resistor inside the equipment, in the output strand chip.
Allowing the simulation of emission without emitting current to the participant and without being able to appreciate any type of alteration in the handling of the equipment, by the operators.
Therefore, the same steps will be followed as in the experimental group.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Victorian Institute of Sport Assessment - Achilles - Baseline
Time Frame: Baseline
|
patient reported outcomes specifically designed for the assessment of pain and function in the achilles tendinopathy.
It has a scale from 0 (worst) to 100 (best).
|
Baseline
|
Victorian Institute of Sport Assessment - Achilles - Week 1
Time Frame: one week at study entry
|
patient reported outcomes specifically designed for the assessment of pain and function in the achilles tendinopathy.
It has a scale from 0 (worst) to 100 (best).
|
one week at study entry
|
Victorian Institute of Sport Assessment - Achilles - Week 2
Time Frame: two week at study entry
|
patient reported outcomes specifically designed for the assessment of pain and function in the achilles tendinopathy.
It has a scale from 0 (worst) to 100 (best).
|
two week at study entry
|
Victorian Institute of Sport Assessment - Achilles - Week 3
Time Frame: three week at study entry
|
patient reported outcomes specifically designed for the assessment of pain and function in the achilles tendinopathy.
It has a scale from 0 (worst) to 100 (best).
|
three week at study entry
|
Victorian Institute of Sport Assessment - Achilles - Week 4
Time Frame: four week at study entry
|
patient reported outcomes specifically designed for the assessment of pain and function in the achilles tendinopathy.
It has a scale from 0 (worst) to 100 (best).
|
four week at study entry
|
Victorian Institute of Sport Assessment - Achilles - Week 5
Time Frame: five week at study entry
|
patient reported outcomes specifically designed for the assessment of pain and function in the achilles tendinopathy.
It has a scale from 0 (worst) to 100 (best).
|
five week at study entry
|
Victorian Institute of Sport Assessment - Achilles - Week 6
Time Frame: six week at study entry
|
patient reported outcomes specifically designed for the assessment of pain and function in the achilles tendinopathy.
It has a scale from 0 (worst) to 100 (best).
|
six week at study entry
|
Victorian Institute of Sport Assessment - Achilles - Week 7
Time Frame: seven week at study entry
|
patient reported outcomes specifically designed for the assessment of pain and function in the achilles tendinopathy.
It has a scale from 0 (worst) to 100 (best).
|
seven week at study entry
|
Victorian Institute of Sport Assessment - Achilles - Week 8
Time Frame: eight week at study entry
|
patient reported outcomes specifically designed for the assessment of pain and function in the achilles tendinopathy.
It has a scale from 0 (worst) to 100 (best).
|
eight week at study entry
|
Victorian Institute of Sport Assessment - Achilles - Week 9
Time Frame: nine week at study entry
|
patient reported outcomes specifically designed for the assessment of pain and function in the achilles tendinopathy.
It has a scale from 0 (worst) to 100 (best).
|
nine week at study entry
|
Victorian Institute of Sport Assessment - Achilles - Week 10
Time Frame: ten week at study entry
|
patient reported outcomes specifically designed for the assessment of pain and function in the achilles tendinopathy.
It has a scale from 0 (worst) to 100 (best).
|
ten week at study entry
|
Victorian Institute of Sport Assessment - Achilles - Week 11
Time Frame: eleven week at study entry
|
patient reported outcomes specifically designed for the assessment of pain and function in the achilles tendinopathy.
It has a scale from 0 (worst) to 100 (best).
|
eleven week at study entry
|
Victorian Institute of Sport Assessment - Achilles - Week 12
Time Frame: twelve week at study entry
|
patient reported outcomes specifically designed for the assessment of pain and function in the achilles tendinopathy.
It has a scale from 0 (worst) to 100 (best).
|
twelve week at study entry
|
Victorian Institute of Sport Assessment - Achilles - Week 26
Time Frame: twenty-six week at study entry
|
patient reported outcomes specifically designed for the assessment of pain and function in the achilles tendinopathy.
It has a scale from 0 (worst) to 100 (best).
|
twenty-six week at study entry
|
Victorian Institute of Sport Assessment - Achilles - Week 52
Time Frame: fifty-two week at study entry
|
patient reported outcomes specifically designed for the assessment of pain and function in the achilles tendinopathy.
It has a scale from 0 (worst) to 100 (best).
|
fifty-two week at study entry
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
visual analog scale - Baseline
Time Frame: Baseline
|
The intensity of pain experienced during a sequence of three monopodal countermovement jumps with both hands on the waist will be evaluated on a graduated scale.
A maximum of three jumps will be performed and the highest jump will be recorded.
Immediately afterwards, participants will be asked to indicate with an "X" on a 100mm line the intensity of pain experienced in the Achilles tendon.
It has a scale from 0 (no pain) to 100 (worst pain).
|
Baseline
|
visual analog scale - Week 1
Time Frame: one week at study entry
|
The intensity of pain experienced during a sequence of three monopodal countermovement jumps with both hands on the waist will be evaluated on a graduated scale.
A maximum of three jumps will be performed and the highest jump will be recorded.
Immediately afterwards, participants will be asked to indicate with an "X" on a 100mm line the intensity of pain experienced in the Achilles tendon.
It has a scale from 0 (no pain) to 100 (worst pain).
|
one week at study entry
|
visual analog scale - Week 2
Time Frame: Two week at study entry
|
The intensity of pain experienced during a sequence of three monopodal countermovement jumps with both hands on the waist will be evaluated on a graduated scale.
A maximum of three jumps will be performed and the highest jump will be recorded.
Immediately afterwards, participants will be asked to indicate with an "X" on a 100mm line the intensity of pain experienced in the Achilles tendon.
It has a scale from 0 (no pain) to 100 (worst pain).
|
Two week at study entry
|
visual analog scale - Week 3
Time Frame: three week at study entry
|
The intensity of pain experienced during a sequence of three monopodal countermovement jumps with both hands on the waist will be evaluated on a graduated scale.
A maximum of three jumps will be performed and the highest jump will be recorded.
Immediately afterwards, participants will be asked to indicate with an "X" on a 100mm line the intensity of pain experienced in the Achilles tendon.
It has a scale from 0 (no pain) to 100 (worst pain).
|
three week at study entry
|
visual analog scale - Week 4
Time Frame: four week at study entry
|
The intensity of pain experienced during a sequence of three monopodal countermovement jumps with both hands on the waist will be evaluated on a graduated scale.
A maximum of three jumps will be performed and the highest jump will be recorded.
Immediately afterwards, participants will be asked to indicate with an "X" on a 100mm line the intensity of pain experienced in the Achilles tendon.
It has a scale from 0 (no pain) to 100 (worst pain).
|
four week at study entry
|
visual analog scale - Week 5
Time Frame: five week at study entry
|
The intensity of pain experienced during a sequence of three monopodal countermovement jumps with both hands on the waist will be evaluated on a graduated scale.
A maximum of three jumps will be performed and the highest jump will be recorded.
Immediately afterwards, participants will be asked to indicate with an "X" on a 100mm line the intensity of pain experienced in the Achilles tendon.
It has a scale from 0 (no pain) to 100 (worst pain).
|
five week at study entry
|
visual analog scale - Week 6
Time Frame: six week at study entry
|
The intensity of pain experienced during a sequence of three monopodal countermovement jumps with both hands on the waist will be evaluated on a graduated scale.
A maximum of three jumps will be performed and the highest jump will be recorded.
Immediately afterwards, participants will be asked to indicate with an "X" on a 100mm line the intensity of pain experienced in the Achilles tendon.
It has a scale from 0 (no pain) to 100 (worst pain).
|
six week at study entry
|
visual analog scale - Week 7
Time Frame: seven week at study entry
|
The intensity of pain experienced during a sequence of three monopodal countermovement jumps with both hands on the waist will be evaluated on a graduated scale.
A maximum of three jumps will be performed and the highest jump will be recorded.
Immediately afterwards, participants will be asked to indicate with an "X" on a 100mm line the intensity of pain experienced in the Achilles tendon.
It has a scale from 0 (no pain) to 100 (worst pain).
|
seven week at study entry
|
visual analog scale - Week 8
Time Frame: eight week at study entry
|
The intensity of pain experienced during a sequence of three monopodal countermovement jumps with both hands on the waist will be evaluated on a graduated scale.
A maximum of three jumps will be performed and the highest jump will be recorded.
Immediately afterwards, participants will be asked to indicate with an "X" on a 100mm line the intensity of pain experienced in the Achilles tendon.
It has a scale from 0 (no pain) to 100 (worst pain).
|
eight week at study entry
|
visual analog scale - Week 9
Time Frame: nine week at study entry
|
The intensity of pain experienced during a sequence of three monopodal countermovement jumps with both hands on the waist will be evaluated on a graduated scale.
A maximum of three jumps will be performed and the highest jump will be recorded.
Immediately afterwards, participants will be asked to indicate with an "X" on a 100mm line the intensity of pain experienced in the Achilles tendon.
It has a scale from 0 (no pain) to 100 (worst pain).
|
nine week at study entry
|
visual analog scale - Week 10
Time Frame: ten week at study entry
|
The intensity of pain experienced during a sequence of three monopodal countermovement jumps with both hands on the waist will be evaluated on a graduated scale.
A maximum of three jumps will be performed and the highest jump will be recorded.
Immediately afterwards, participants will be asked to indicate with an "X" on a 100mm line the intensity of pain experienced in the Achilles tendon.
It has a scale from 0 (no pain) to 100 (worst pain).
|
ten week at study entry
|
visual analog scale - Week 11
Time Frame: eleven week at study entry
|
The intensity of pain experienced during a sequence of three monopodal countermovement jumps with both hands on the waist will be evaluated on a graduated scale.
A maximum of three jumps will be performed and the highest jump will be recorded.
Immediately afterwards, participants will be asked to indicate with an "X" on a 100mm line the intensity of pain experienced in the Achilles tendon.
It has a scale from 0 (no pain) to 100 (worst pain).
|
eleven week at study entry
|
visual analog scale - Week 12
Time Frame: twelve week at study entry
|
The intensity of pain experienced during a sequence of three monopodal countermovement jumps with both hands on the waist will be evaluated on a graduated scale.
A maximum of three jumps will be performed and the highest jump will be recorded.
Immediately afterwards, participants will be asked to indicate with an "X" on a 100mm line the intensity of pain experienced in the Achilles tendon.
It has a scale from 0 (no pain) to 100 (worst pain).
|
twelve week at study entry
|
visual analog scale - Week 26
Time Frame: twenty-six week at study entry
|
The intensity of pain experienced during a sequence of three monopodal countermovement jumps with both hands on the waist will be evaluated on a graduated scale.
A maximum of three jumps will be performed and the highest jump will be recorded.
Immediately afterwards, participants will be asked to indicate with an "X" on a 100mm line the intensity of pain experienced in the Achilles tendon.
It has a scale from 0 (no pain) to 100 (worst pain).
|
twenty-six week at study entry
|
visual analog scale - Week 52
Time Frame: fifty-two week at study entry
|
The intensity of pain experienced during a sequence of three monopodal countermovement jumps with both hands on the waist will be evaluated on a graduated scale.
A maximum of three jumps will be performed and the highest jump will be recorded.
Immediately afterwards, participants will be asked to indicate with an "X" on a 100mm line the intensity of pain experienced in the Achilles tendon.
It has a scale from 0 (no pain) to 100 (worst pain).
|
fifty-two week at study entry
|
The Foot and Ankle Ability Measure - Baseline
Time Frame: Baseline
|
an evaluative instrument that assesses functional limitations for those with foot- and ankle-related disorders.
it's a patient reported outcomes which allows to quantify sport activity and participation.
It has a scale from 0 (worst) to 100 (best).
It consists of 29 questions, divided into 2 subscales, activities of daily living and sports activities.
The criterion for discharge is a value greater than or equal to 90 points.
|
Baseline
|
The Foot and Ankle Ability Measure - Week 1
Time Frame: one week at study entry
|
an evaluative instrument that assesses functional limitations for those with foot- and ankle-related disorders.
it's a patient reported outcomes which allows to quantify sport activity and participation.
It has a scale from 0 (worst) to 100 (best).
It consists of 29 questions, divided into 2 subscales, activities of daily living and sports activities.
The criterion for discharge is a value greater than or equal to 90 points.
|
one week at study entry
|
The Foot and Ankle Ability Measure - Week 2
Time Frame: two week at study entry
|
an evaluative instrument that assesses functional limitations for those with foot- and ankle-related disorders.
it's a patient reported outcomes which allows to quantify sport activity and participation.
It has a scale from 0 (worst) to 100 (best).
It consists of 29 questions, divided into 2 subscales, activities of daily living and sports activities.
The criterion for discharge is a value greater than or equal to 90 points.
|
two week at study entry
|
The Foot and Ankle Ability Measure - Week 3
Time Frame: three week at study entry
|
an evaluative instrument that assesses functional limitations for those with foot- and ankle-related disorders.
it's a patient reported outcomes which allows to quantify sport activity and participation.
It has a scale from 0 (worst) to 100 (best).
It consists of 29 questions, divided into 2 subscales, activities of daily living and sports activities.
The criterion for discharge is a value greater than or equal to 90 points.
|
three week at study entry
|
The Foot and Ankle Ability Measure - Week 4
Time Frame: four week at study entry
|
an evaluative instrument that assesses functional limitations for those with foot- and ankle-related disorders.
it's a patient reported outcomes which allows to quantify sport activity and participation.
It has a scale from 0 (worst) to 100 (best).
It consists of 29 questions, divided into 2 subscales, activities of daily living and sports activities.
The criterion for discharge is a value greater than or equal to 90 points.
|
four week at study entry
|
The Foot and Ankle Ability Measure - Week 5
Time Frame: five week at study entry
|
an evaluative instrument that assesses functional limitations for those with foot- and ankle-related disorders.
it's a patient reported outcomes which allows to quantify sport activity and participation.
It has a scale from 0 (worst) to 100 (best).
It consists of 29 questions, divided into 2 subscales, activities of daily living and sports activities.
The criterion for discharge is a value greater than or equal to 90 points.
|
five week at study entry
|
The Foot and Ankle Ability Measure - Week 6
Time Frame: six week at study entry
|
an evaluative instrument that assesses functional limitations for those with foot- and ankle-related disorders.
it's a patient reported outcomes which allows to quantify sport activity and participation.
It has a scale from 0 (worst) to 100 (best).
It consists of 29 questions, divided into 2 subscales, activities of daily living and sports activities.
The criterion for discharge is a value greater than or equal to 90 points.
|
six week at study entry
|
The Foot and Ankle Ability Measure - Week 7
Time Frame: seven week at study entry
|
an evaluative instrument that assesses functional limitations for those with foot- and ankle-related disorders.
it's a patient reported outcomes which allows to quantify sport activity and participation.
It has a scale from 0 (worst) to 100 (best).
It consists of 29 questions, divided into 2 subscales, activities of daily living and sports activities.
The criterion for discharge is a value greater than or equal to 90 points.
|
seven week at study entry
|
The Foot and Ankle Ability Measure - Week 8
Time Frame: eight week at study entry
|
an evaluative instrument that assesses functional limitations for those with foot- and ankle-related disorders.
it's a patient reported outcomes which allows to quantify sport activity and participation.
It has a scale from 0 (worst) to 100 (best).
It consists of 29 questions, divided into 2 subscales, activities of daily living and sports activities.
The criterion for discharge is a value greater than or equal to 90 points.
|
eight week at study entry
|
The Foot and Ankle Ability Measure - Week 9
Time Frame: nine week at study entry
|
an evaluative instrument that assesses functional limitations for those with foot- and ankle-related disorders.
it's a patient reported outcomes which allows to quantify sport activity and participation.
It has a scale from 0 (worst) to 100 (best).
It consists of 29 questions, divided into 2 subscales, activities of daily living and sports activities.
The criterion for discharge is a value greater than or equal to 90 points.
|
nine week at study entry
|
The Foot and Ankle Ability Measure - Week 10
Time Frame: ten week at study entry
|
an evaluative instrument that assesses functional limitations for those with foot- and ankle-related disorders.
it's a patient reported outcomes which allows to quantify sport activity and participation.
It has a scale from 0 (worst) to 100 (best).
It consists of 29 questions, divided into 2 subscales, activities of daily living and sports activities.
The criterion for discharge is a value greater than or equal to 90 points.
|
ten week at study entry
|
The Foot and Ankle Ability Measure - Week 11
Time Frame: eleven week at study entry
|
an evaluative instrument that assesses functional limitations for those with foot- and ankle-related disorders.
it's a patient reported outcomes which allows to quantify sport activity and participation.
It has a scale from 0 (worst) to 100 (best).
It consists of 29 questions, divided into 2 subscales, activities of daily living and sports activities.
The criterion for discharge is a value greater than or equal to 90 points.
|
eleven week at study entry
|
The Foot and Ankle Ability Measure - Week 12
Time Frame: twelve week at study entry
|
an evaluative instrument that assesses functional limitations for those with foot- and ankle-related disorders.
it's a patient reported outcomes which allows to quantify sport activity and participation.
It has a scale from 0 (worst) to 100 (best).
It consists of 29 questions, divided into 2 subscales, activities of daily living and sports activities.
The criterion for discharge is a value greater than or equal to 90 points.
|
twelve week at study entry
|
The Foot and Ankle Ability Measure - Week 26
Time Frame: twenty-six week at study entry
|
an evaluative instrument that assesses functional limitations for those with foot- and ankle-related disorders.
it's a patient reported outcomes which allows to quantify sport activity and participation.
It has a scale from 0 (worst) to 100 (best).
It consists of 29 questions, divided into 2 subscales, activities of daily living and sports activities.
The criterion for discharge is a value greater than or equal to 90 points.
|
twenty-six week at study entry
|
The Foot and Ankle Ability Measure - Week 52
Time Frame: fifty-two week at study entry
|
an evaluative instrument that assesses functional limitations for those with foot- and ankle-related disorders.
it's a patient reported outcomes which allows to quantify sport activity and participation.
It has a scale from 0 (worst) to 100 (best).
It consists of 29 questions, divided into 2 subscales, activities of daily living and sports activities.
The criterion for discharge is a value greater than or equal to 90 points.
|
fifty-two week at study entry
|
ultrasound Shear Wave elastography - baseline
Time Frame: Baseline
|
Shear Wave Elastography (SWS), which consists of a special ultrasound methodology that allows quantitative characterization of the elastic capacity of a tissue through the propagation velocity of the ultrasound wave. The Siemens Acuson S2000 system with a model 9L4 linear transducer will be used. The patients will be placed on a table in ventral decubitus and the ankle outside the plane of the table in neutral position. To determine the point to be scanned, the maximum perpendicular distance between the anterior and posterior limits of the tendon between 2 to 6 cm from the insertion in the calcaneus will be taken and this value will be reported in mm. The SWS value will be expressed in m/s. The range of SWS is 0-9 m/s. The standard SWS measurement window size shall be 1cm2 , with a region of interest of 3mm. Three measurements will be recorded in each plane (regions of interest) where homogeneous tissue is considered and the average value of the 6 measurements will be reported. |
Baseline
|
ultrasound Shear Wave elastography - Week 4
Time Frame: four week at study entry
|
Shear Wave Elastography (SWS), which consists of a special ultrasound methodology that allows quantitative characterization of the elastic capacity of a tissue through the propagation velocity of the ultrasound wave. The Siemens Acuson S2000 system with a model 9L4 linear transducer will be used. The patients will be placed on a table in ventral decubitus and the ankle outside the plane of the table in neutral position. To determine the point to be scanned, the maximum perpendicular distance between the anterior and posterior limits of the tendon between 2 to 6 cm from the insertion in the calcaneus will be taken and this value will be reported in mm. The SWS value will be expressed in m/s. The range of SWS is 0-9 m/s. The standard SWS measurement window size shall be 1cm2 , with a region of interest of 3mm. Three measurements will be recorded in each plane (regions of interest) where homogeneous tissue is considered and the average value of the 6 measurements will be reported. |
four week at study entry
|
ultrasound Shear Wave elastography - Week 8
Time Frame: eight week at study entry
|
Shear Wave Elastography (SWS), which consists of a special ultrasound methodology that allows quantitative characterization of the elastic capacity of a tissue through the propagation velocity of the ultrasound wave. The Siemens Acuson S2000 system with a model 9L4 linear transducer will be used. The patients will be placed on a table in ventral decubitus and the ankle outside the plane of the table in neutral position. To determine the point to be scanned, the maximum perpendicular distance between the anterior and posterior limits of the tendon between 2 to 6 cm from the insertion in the calcaneus will be taken and this value will be reported in mm. The SWS value will be expressed in m/s. The range of SWS is 0-9 m/s. The standard SWS measurement window size shall be 1cm2 , with a region of interest of 3mm. Three measurements will be recorded in each plane (regions of interest) where homogeneous tissue is considered and the average value of the 6 measurements will be reported. |
eight week at study entry
|
ultrasound Shear Wave elastography - Week 12
Time Frame: twelve week at study entry
|
Shear Wave Elastography (SWS), which consists of a special ultrasound methodology that allows quantitative characterization of the elastic capacity of a tissue through the propagation velocity of the ultrasound wave. The Siemens Acuson S2000 system with a model 9L4 linear transducer will be used. The patients will be placed on a table in ventral decubitus and the ankle outside the plane of the table in neutral position. To determine the point to be scanned, the maximum perpendicular distance between the anterior and posterior limits of the tendon between 2 to 6 cm from the insertion in the calcaneus will be taken and this value will be reported in mm. The SWS value will be expressed in m/s. The range of SWS is 0-9 m/s. The standard SWS measurement window size shall be 1cm2 , with a region of interest of 3mm. Three measurements will be recorded in each plane (regions of interest) where homogeneous tissue is considered and the average value of the 6 measurements will be reported. |
twelve week at study entry
|
ultrasound Shear Wave elastography - Week 26
Time Frame: twenty-six week at study entry
|
Shear Wave Elastography (SWS), which consists of a special ultrasound methodology that allows quantitative characterization of the elastic capacity of a tissue through the propagation velocity of the ultrasound wave. The Siemens Acuson S2000 system with a model 9L4 linear transducer will be used. The patients will be placed on a table in ventral decubitus and the ankle outside the plane of the table in neutral position. To determine the point to be scanned, the maximum perpendicular distance between the anterior and posterior limits of the tendon between 2 to 6 cm from the insertion in the calcaneus will be taken and this value will be reported in mm. The SWS value will be expressed in m/s. The range of SWS is 0-9 m/s. The standard SWS measurement window size shall be 1cm2 , with a region of interest of 3mm. Three measurements will be recorded in each plane (regions of interest) where homogeneous tissue is considered and the average value of the 6 measurements will be reported. |
twenty-six week at study entry
|
ultrasound Shear Wave elastography - Week 52
Time Frame: fifty-two week at study entry
|
Shear Wave Elastography (SWS), which consists of a special ultrasound methodology that allows quantitative characterization of the elastic capacity of a tissue through the propagation velocity of the ultrasound wave. The Siemens Acuson S2000 system with a model 9L4 linear transducer will be used. The patients will be placed on a table in ventral decubitus and the ankle outside the plane of the table in neutral position. To determine the point to be scanned, the maximum perpendicular distance between the anterior and posterior limits of the tendon between 2 to 6 cm from the insertion in the calcaneus will be taken and this value will be reported in mm. The SWS value will be expressed in m/s. The range of SWS is 0-9 m/s. The standard SWS measurement window size shall be 1cm2 , with a region of interest of 3mm. Three measurements will be recorded in each plane (regions of interest) where homogeneous tissue is considered and the average value of the 6 measurements will be reported. |
fifty-two week at study entry
|
Vienna Achilles tendon morphological score - MRI - baseline
Time Frame: Baseline
|
A 1.5T Siemens Healthcare 1.5T scanner will be used for the MRI evaluation, using a gradient strength of 40 mT/m and an 8-channel coil. The standard MRI protocol will be identical for all examinations and will consist of a localizer set and three morphological MR sequences: 1) a sagittal fat-suppressed sequence; 2) a sagittal T1 sagittal spin echo (SE) sequence and 3) a T2-w sequence. Once the images are obtained, they will be evaluated with the "Vienna Achilles tendon morphological score" (VIMATS) protocol proposed by Apprich S. (2021) which conforms a semiquantitative rating scale where the score is composed of four different parameters: (1) thickness, (2) continuity, (3) signal and (4) associated pathologies. It has a continuous numerical scale from 0 to 100 where the higher the score, the better the patient's stage. |
Baseline
|
Vienna Achilles tendon morphological score - MRI - Week 4
Time Frame: four week at study entry
|
A 1.5T Siemens Healthcare 1.5T scanner will be used for the MRI evaluation, using a gradient strength of 40 mT/m and an 8-channel coil. The standard MRI protocol will be identical for all examinations and will consist of a localizer set and three morphological MR sequences: 1) a sagittal fat-suppressed sequence; 2) a sagittal T1 sagittal spin echo (SE) sequence and 3) a T2-w sequence. Once the images are obtained, they will be evaluated with the "Vienna Achilles tendon morphological score" (VIMATS) protocol proposed by Apprich S. (2021) which conforms a semiquantitative rating scale where the score is composed of four different parameters: (1) thickness, (2) continuity, (3) signal and (4) associated pathologies. It has a continuous numerical scale from 0 to 100 where the higher the score, the better the patient's stage. |
four week at study entry
|
Vienna Achilles tendon morphological score - MRI - Week 8
Time Frame: eight week at study entry
|
A 1.5T Siemens Healthcare 1.5T scanner will be used for the MRI evaluation, using a gradient strength of 40 mT/m and an 8-channel coil. The standard MRI protocol will be identical for all examinations and will consist of a localizer set and three morphological MR sequences: 1) a sagittal fat-suppressed sequence; 2) a sagittal T1 sagittal spin echo (SE) sequence and 3) a T2-w sequence. Once the images are obtained, they will be evaluated with the "Vienna Achilles tendon morphological score" (VIMATS) protocol proposed by Apprich S. (2021) which conforms a semiquantitative rating scale where the score is composed of four different parameters: (1) thickness, (2) continuity, (3) signal and (4) associated pathologies. It has a continuous numerical scale from 0 to 100 where the higher the score, the better the patient's stage. |
eight week at study entry
|
Vienna Achilles tendon morphological score - MRI - Week 12
Time Frame: twelve week at study entry
|
A 1.5T Siemens Healthcare 1.5T scanner will be used for the MRI evaluation, using a gradient strength of 40 mT/m and an 8-channel coil. The standard MRI protocol will be identical for all examinations and will consist of a localizer set and three morphological MR sequences: 1) a sagittal fat-suppressed sequence; 2) a sagittal T1 sagittal spin echo (SE) sequence and 3) a T2-w sequence. Once the images are obtained, they will be evaluated with the "Vienna Achilles tendon morphological score" (VIMATS) protocol proposed by Apprich S. (2021) which conforms a semiquantitative rating scale where the score is composed of four different parameters: (1) thickness, (2) continuity, (3) signal and (4) associated pathologies. It has a continuous numerical scale from 0 to 100 where the higher the score, the better the patient's stage. |
twelve week at study entry
|
Vienna Achilles tendon morphological score - MRI - Week 26
Time Frame: twenty-six week at study entry
|
A 1.5T Siemens Healthcare 1.5T scanner will be used for the MRI evaluation, using a gradient strength of 40 mT/m and an 8-channel coil. The standard MRI protocol will be identical for all examinations and will consist of a localizer set and three morphological MR sequences: 1) a sagittal fat-suppressed sequence; 2) a sagittal T1 sagittal spin echo (SE) sequence and 3) a T2-w sequence. Once the images are obtained, they will be evaluated with the "Vienna Achilles tendon morphological score" (VIMATS) protocol proposed by Apprich S. (2021) which conforms a semiquantitative rating scale where the score is composed of four different parameters: (1) thickness, (2) continuity, (3) signal and (4) associated pathologies. It has a continuous numerical scale from 0 to 100 where the higher the score, the better the patient's stage. |
twenty-six week at study entry
|
Vienna Achilles tendon morphological score - MRI - Week 52
Time Frame: fifty-two week at study entry
|
A 1.5T Siemens Healthcare 1.5T scanner will be used for the MRI evaluation, using a gradient strength of 40 mT/m and an 8-channel coil. The standard MRI protocol will be identical for all examinations and will consist of a localizer set and three morphological MR sequences: 1) a sagittal fat-suppressed sequence; 2) a sagittal T1 sagittal spin echo (SE) sequence and 3) a T2-w sequence. Once the images are obtained, they will be evaluated with the "Vienna Achilles tendon morphological score" (VIMATS) protocol proposed by Apprich S. (2021) which conforms a semiquantitative rating scale where the score is composed of four different parameters: (1) thickness, (2) continuity, (3) signal and (4) associated pathologies. It has a continuous numerical scale from 0 to 100 where the higher the score, the better the patient's stage. |
fifty-two week at study entry
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Santiago M d'Almeida, PT SCS, Maimonides University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 5694
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Achilles Tendinopathy
-
University of CalgarySport Science Association of Alberta (SSAA)UnknownAchilles Tendinopathy | Achilles Tendon Enthesopathy | Mid-Portion Achilles Tendinopathy | Insertional Achilles Tendinopathy | Non-Insertional Achilles TendinopathyCanada
-
Krankenhaus Barmherzige Schwestern LinzActive, not recruitingAchilles Tendinopathy | Insertional Achilles TendinopathyAustria
-
University of DelawareActive, not recruitingAchilles Tendinopathy | Achillodynia | Achilles Tendon Pain | Achilles Tendonitis | Achilles DegenerationUnited States
-
Guna S.p.aRecruitingTendinopathy | Achilles Tendinopathy | Insertional Achilles Tendinopathy | PeritendinitisItaly
-
Chinese University of Hong KongNot yet recruitingAchilles Tendinopathy | Achilles Tendon RuptureHong Kong
-
Philadelphia College of Osteopathic MedicineRecruitingAchilles Tendinopathy | Achilles Tendon Pain | Achilles Tendonitis | Ankle StrainUnited States
-
University of DelawareRecruitingSever's Disease | Achilles Tendinopathy | Insertional Achilles Tendinopathy | Apophysitis; CalcaneusUnited States
-
University of Gran RosarioRecruitingTendon Injuries | Achilles Tendinopathy | Achilles Tendon PainArgentina
-
Chinese University of Hong KongNot yet recruiting
-
North Park PodiatryRecruiting
Clinical Trials on low intensity percutaneous musculoskeletal electrolysis
-
University of SalamancaCompleted
-
University of SalamancaCompletedPain | Analgesia | Pain Modulation | Percutaneous Electrolysis | Endogenous Analgesia SystemSpain
-
Universidad Rey Juan CarlosWithdrawnPlantar Heel Pain, Plantar FasciosisSpain
-
Universidad Complutense de MadridCompletedMyofascial Pain | Trigger Point Pain, MyofascialSpain
-
Universidad Francisco de VitoriaCompletedMuscle Pain | Knee Pain ChronicSpain
-
Universidad Europea de MadridCompleted
-
Universidad de ZaragozaMinistry of Health, Kuwait; Universidad San JorgeCompletedPlantar Fascitis | Myofacial Pain Syndromes | Trigger Point Pain, MyofascialKuwait
-
University of SalamancaRecruitingShoulder Pain | Myofascial Pain SyndromeSpain
-
Universidad Rey Juan CarlosCompleted
-
Universidad Rey Juan CarlosCompletedSupraspinatus TendinopathySpain